Literature DB >> 22280230

In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival.

Mauricio A Moreno1, Beth S Edeiken-Monroe, Eric R Siegel, Steven I Sherman, Gary L Clayman.   

Abstract

BACKGROUND: Ultrasound (US) of the central neck compartment (CNC) is considered of limited sensitivity for nodal spread in papillary thyroid cancer (PTC); elective neck dissection is commonly advocated even in the absence of sonographic abnormalities. We hypothesized that US is an accurate predictor for long-term disease-free survival, regardless of the use of elective central neck dissection in patients with PTC.
METHODS: A retrospective chart review of 331 consecutive PTC patients treated with total thyroidectomy at M.D. Anderson Cancer Center between 1996 and 2003 was performed. Information retrieved included preoperative sonographic status of the CNC, surgical treatment of the neck, demographics, cancer staging, histopathological variables and use of adjuvant treatment. The endpoints for the study were nodal recurrence and survival.
RESULTS: There were 112 males and 219 females with a median age of 44 years (range 11-87). The median follow-up time for the series was 71.5 months (range 12.7-148.7). There were 151 (45.6%) patients with a T1, 58 (17.5%) with a T2, 70 (21.1%) with a T3, and 52 (15.7%) with a T4. Preoperative sonographic abnormalities were present in the CNC in 79 (23.9%) patients. During the surveillance period, 11 (3.2%) patients recurred in the central neck, with an average time for recurrence of 22.8 months. Advanced T stage (T3/T4) and abnormal US were independent prognostic factors for recurrence in the central neck (p=0.013 and p=0.005 respectively). There were 119 (35%) patients with a sonographically negative central compartment who underwent elective central neck dissection; 85 of them (71.4%) were found to be histopathologically N(+) while 34 (28.6%) were pN0. There were no differences in overall survival (p=0.32), disease specific survival (DSS; p=0.49), and recurrence-free survival (p=0.32) between these two groups. Preoperative US of the CNC was an age-independent predictor for overall survival (p<0.001), DSS (p=0.0097), and disease-free survival (p=0.0005) on bivariate Cox regression.
CONCLUSIONS: US of the central compartment is an age-independent predictor for survival and CNC recurrence-free survival in PTC. Prophylactic neck dissection of the central compartment does not improve long-term disease control, regardless of the histopathological status of the lymph nodes retrieved. Our findings emphasize the ability of US to clinically detect relevant nodal disease and support conservative management of the CNC in the absence of abnormal findings.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22280230      PMCID: PMC3968956          DOI: 10.1089/thy.2011.0121

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  31 in total

Review 1.  Central compartment dissection for well differentiated thyroid cancer … and the band plays on.

Authors:  N Gopalakrishna Iyer; Ashok R Shaha
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2011-04       Impact factor: 2.064

Review 2.  Thyroid cancer.

Authors:  O Gimm
Journal:  Cancer Lett       Date:  2001-02-26       Impact factor: 8.679

Review 3.  Management of a solitary thyroid nodule.

Authors:  E L Mazzaferri
Journal:  N Engl J Med       Date:  1993-02-25       Impact factor: 91.245

4.  Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection.

Authors:  Nobuyuki Wada; Quan-Yang Duh; Kiminori Sugino; Hiroyuki Iwasaki; Kaori Kameyama; Takashi Mimura; Koichi Ito; Hiroshi Takami; Yoshinori Takanashi
Journal:  Ann Surg       Date:  2003-03       Impact factor: 12.969

5.  Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid.

Authors:  Yasuhiro Ito; Chisato Tomoda; Takashi Uruno; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

6.  Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer.

Authors:  Maria A Kouvaraki; Suzanne E Shapiro; Bruno D Fornage; Beth S Edeiken-Monro; Steven I Sherman; Rena Vassilopoulou-Sellin; Jeffrey E Lee; Douglas B Evans
Journal:  Surgery       Date:  2003-12       Impact factor: 3.982

7.  Surgeon-performed ultrasound in the management of thyroid malignancy.

Authors:  Carmen C Solorzano; Denise M Carneiro; Marcela Ramirez; Theresa M Lee; George L Irvin
Journal:  Am Surg       Date:  2004-07       Impact factor: 0.688

8.  Lymph node surgery in papillary thyroid carcinoma.

Authors:  Ernst Gemsenjäger; Aurel Perren; Burkhardt Seifert; Georges Schüler; Ingrid Schweizer; Philipp U Heitz
Journal:  J Am Coll Surg       Date:  2003-08       Impact factor: 6.113

9.  Safety of modified radical neck dissection for differentiated thyroid carcinoma.

Authors:  Michael E Kupferman; D Michael Patterson; Susan J Mandel; Virginia LiVolsi; Randal S Weber
Journal:  Laryngoscope       Date:  2004-03       Impact factor: 3.325

10.  An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid.

Authors:  Yasuhiro Ito; Takashi Uruno; Keiichi Nakano; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Tamotsu Yokozawa; Fumio Matsuzuka; Seiji Kuma; Kanji Kuma; Akira Miyauchi
Journal:  Thyroid       Date:  2003-04       Impact factor: 6.568

View more
  28 in total

1.  Macrometastasis in Papillary Thyroid Cancer Patients is Associated with Higher Recurrence in Lateral Neck Nodes.

Authors:  Soo Young Kim; Bup-Woo Kim; Ju Yeon Pyo; Soon Won Hong; Hang-Seok Chang; Cheong Soo Park
Journal:  World J Surg       Date:  2018-01       Impact factor: 3.352

Review 2.  Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review.

Authors:  Elisabeth Mamelle; Isabelle Borget; Sophie Leboulleux; Haïtham Mirghani; Carlos Suárez; Phillip K Pellitteri; Ashok R Shaha; Marc Hamoir; K Thomas Robbins; Avi Khafif; Juan P Rodrigo; Carl E Silver; Alessandra Rinaldo; Alfio Ferlito; Dana M Hartl
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-11       Impact factor: 2.503

3.  Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection.

Authors:  I J Nixon; L Y Wang; I Ganly; S G Patel; L G Morris; J C Migliacci; R M Tuttle; J P Shah; A R Shaha
Journal:  Br J Surg       Date:  2015-10-29       Impact factor: 6.939

4.  Sentinel node biopsy in papillary thyroid cancer--what is the potential?

Authors:  S P Balasubramanian; J Brignall; H Y Lin; T J Stephenson; J Wadsley; B J Harrison; W L Craig; L Smart; Z Krukowski
Journal:  Langenbecks Arch Surg       Date:  2014-01-21       Impact factor: 3.445

Review 5.  Nodal metastases in thyroid cancer: prognostic implications and management.

Authors:  Laura Y Wang; Ian Ganly
Journal:  Future Oncol       Date:  2016-03-07       Impact factor: 3.404

Review 6.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

7.  Intraoperative ultrasonography is useful in surgical management of neck metastases in differentiated thyroid cancers.

Authors:  Burak Ertas; Hakan Kaya; Neslihan Kurtulmus; Abdullah Yakupoglu; Serdar Giray; Omer Faruk Unal; Mete Duren
Journal:  Endocrine       Date:  2014-05-27       Impact factor: 3.633

8.  Disease severity and radioactive iodine use for thyroid cancer.

Authors:  M R Haymart; D G Muenz; A K Stewart; J J Griggs; M Banerjee
Journal:  J Clin Endocrinol Metab       Date:  2013-01-15       Impact factor: 5.958

9.  Adequacy of pathology reports of specimens from patients with differentiated thyroid cancer.

Authors:  Ma Luisa Isidro; Gloria Lugo; Olga Fidalgo; Sara García-Arias
Journal:  Endocr Pathol       Date:  2012-12       Impact factor: 3.943

Review 10.  The pros and cons of routine central compartment neck dissection for clinically nodal negative (cN0) papillary thyroid cancer.

Authors:  Ai Chen Chan; Brian Hung Hin Lang; Kai Pun Wong
Journal:  Gland Surg       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.